Q&As on Listed Issuers | Securities Investors Association (Singapore)

Sort By:

Company Name:

Market:

Category :

Array
(
)
Array
(
    [cid] => 23896,11661
    [company] => Aoxin Q 
)
Array
(
    [post_type] => annual_reports
    [showposts] => -1
    [meta_key] => agm_date
    [orderby] => Array
        (
            [meta_value] => DESC
            [title] => ASC
        )

    [order] => DESC
    [paged] => 1
    [meta_query] => Array
        (
            [key] => mark_as_upcoming_qa
            [value] => 
            [compare] => =
        )

    [post__in] => Array
        (
            [0] => 23896
            [1] => 11661
        )

)

Array
(
)
Array
(
    [cid] => 23896,11661
    [company] => Aoxin Q 
)
Array
(
    [post_type] => annual_reports
    [showposts] => 12
    [meta_key] => agm_date
    [orderby] => Array
        (
            [meta_value] => DESC
            [title] => ASC
        )

    [order] => DESC
    [paged] => 1
    [meta_query] => Array
        (
            [key] => mark_as_upcoming_qa
            [value] => 
            [compare] => =
        )

    [post__in] => Array
        (
            [0] => 23896
            [1] => 11661
        )

)

AGM/EGM Date	Company	Market	Category	Annual Report/EGM Circular	SIAS Questions	Company Response
AGM/EGM Date: 27/04/2026	27/04/2026	Company: Aoxin Q & M Dental Group Ltd	Aoxin Q & M Dental Group Ltd	Market: Catalist	Catalist	Category: AGM	AGM	Annual Report/EGM Circular: Download	Download	SIAS Questions	In light of the limited geographic expansion since listing and recent management changes... Read More	Company Response	As disclosed in the Company’s Annual Reports for FY2024 and FY2025, the number of dentists... Read More
AGM/EGM Date: 28/04/2022	28/04/2022	Company: Aoxin Q & M Dental Group Ltd	Aoxin Q & M Dental Group Ltd	Market: Catalist	Catalist	Category: AGM	AGM	Annual Report/EGM Circular: Download	Download	SIAS Questions	Has Acumen’s performance met the board/management’s expectations since its acquisition?... Read More	Company Response	As stated in the Company's Circular dated 14 October 2021, the rationale for the acquisition of a 49%... Read More

Upcoming Q&A

Your shortcut to staying informed

Subscribe now and get direct updates on Q&As and corporate action matters!

By clicking submit, you agree to our privacy statement, collection, use and/or disclosure of your
personal data to the extent necessary to provide you with this service.